Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,679 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study.
Plitman E, Chavez S, Nakajima S, Iwata Y, Chung JK, Caravaggio F, Kim J, Alshehri Y, Chakravarty MM, De Luca V, Remington G, Gerretsen P, Graff-Guerrero A. Plitman E, et al. Among authors: nakajima s. Psychiatry Res Neuroimaging. 2018 Mar 30;273:16-24. doi: 10.1016/j.pscychresns.2018.01.004. Epub 2018 Jan 31. Psychiatry Res Neuroimaging. 2018. PMID: 29414127
Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of 1H-MRS studies.
Iwata Y, Nakajima S, Plitman E, Mihashi Y, Caravaggio F, Chung JK, Kim J, Gerretsen P, Mimura M, Remington G, Graff-Guerrero A. Iwata Y, et al. Among authors: nakajima s. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Aug 30;86:340-352. doi: 10.1016/j.pnpbp.2018.03.016. Epub 2018 Mar 23. Prog Neuropsychopharmacol Biol Psychiatry. 2018. PMID: 29580804
Kynurenine pathway in depression: A systematic review and meta-analysis.
Ogyu K, Kubo K, Noda Y, Iwata Y, Tsugawa S, Omura Y, Wada M, Tarumi R, Plitman E, Moriguchi S, Miyazaki T, Uchida H, Graff-Guerrero A, Mimura M, Nakajima S. Ogyu K, et al. Among authors: nakajima s. Neurosci Biobehav Rev. 2018 Jul;90:16-25. doi: 10.1016/j.neubiorev.2018.03.023. Epub 2018 Mar 30. Neurosci Biobehav Rev. 2018. PMID: 29608993
Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies.
Moriguchi S, Takamiya A, Noda Y, Horita N, Wada M, Tsugawa S, Plitman E, Sano Y, Tarumi R, ElSalhy M, Katayama N, Ogyu K, Miyazaki T, Kishimoto T, Graff-Guerrero A, Meyer JH, Blumberger DM, Daskalakis ZJ, Mimura M, Nakajima S. Moriguchi S, et al. Among authors: nakajima s. Mol Psychiatry. 2019 Jul;24(7):952-964. doi: 10.1038/s41380-018-0252-9. Epub 2018 Oct 12. Mol Psychiatry. 2019. PMID: 30315224 Free PMC article.
Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study.
Iwata Y, Nakajima S, Plitman E, Caravaggio F, Kim J, Shah P, Mar W, Chavez S, De Luca V, Mimura M, Remington G, Gerretsen P, Graff-Guerrero A. Iwata Y, et al. Among authors: nakajima s. Biol Psychiatry. 2019 Apr 1;85(7):596-605. doi: 10.1016/j.biopsych.2018.09.009. Epub 2018 Sep 26. Biol Psychiatry. 2019. PMID: 30389132
Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study.
Tarumi R, Tsugawa S, Noda Y, Plitman E, Honda S, Matsushita K, Chavez S, Sawada K, Wada M, Matsui M, Fujii S, Miyazaki T, Chakravarty MM, Uchida H, Remington G, Graff-Guerrero A, Mimura M, Nakajima S. Tarumi R, et al. Among authors: nakajima s. Neuropsychopharmacology. 2020 Mar;45(4):632-640. doi: 10.1038/s41386-019-0589-z. Epub 2019 Dec 16. Neuropsychopharmacology. 2020. PMID: 31842203 Free PMC article.
Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies.
Nakahara T, Tsugawa S, Noda Y, Ueno F, Honda S, Kinjo M, Segawa H, Hondo N, Mori Y, Watanabe H, Nakahara K, Yoshida K, Wada M, Tarumi R, Iwata Y, Plitman E, Moriguchi S, de la Fuente-Sandoval C, Uchida H, Mimura M, Graff-Guerrero A, Nakajima S. Nakahara T, et al. Among authors: nakajima s. Mol Psychiatry. 2022 Jan;27(1):744-757. doi: 10.1038/s41380-021-01297-6. Epub 2021 Sep 28. Mol Psychiatry. 2022. PMID: 34584230 Review.
2,679 results